New Delhi: A top Army hospital in Delhi has performed India's "first-ever" left ventricular assist device (LVAD) implantation using a cutting-edge device at a government institution, the defence ...

The Novacor LVAD device requires systemic anticoagulation to prevent thromboembolism (risk: 5–7%). The incidence of primary device failure is very rare. [11] The Novacor LVAD was approved as a ...

It is a continuous flow reduced pulsatility LVAD that is approved by the Food ... mandate comprehensive monitoring and titration of anticoagulation levels. The performance can be adapted by ...

Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapies, with the late-stage asset tecarfarin, a new ...